Company Profiles

driven by the PitchBook Platform

Ablative Solutions

Description

Developer of therapies and medical tools for treating hypertension designed to address the significant unmet clinical need of systemic hypertension. The company's biomedical device, Peregrine System Infusion Catheter, is a new catheter-based approach for percutaneous delivery of diagnostic and therapeutic agents into the area surrounding the peripheral blood vessels, enabling doctors to easily treat hypertension.

2011

Founded

PRIVATE

Status

1-10

Employees

Series C

Latest Deal Type

$17.9M

Latest Deal Amount

$46.3M

Total Amount Raised

Description

Developer of therapies and medical tools for treating hypertension designed to address the significant unmet clinical need of systemic hypertension. The company's biomedical device, Peregrine System Infusion Catheter, is a new catheter-based approach for percutaneous delivery of diagnostic and therapeutic agents into the area surrounding the peripheral blood vessels, enabling doctors to easily treat hypertension.

Website:

www.ablativesolutions.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

350 East Michigan Avenue Suite 300 Kalamazoo, MI 49007United States +1 (650) 321-6884
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ablative Solutions's full profile, request a free trial.

Ablative Solutions Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ablative Solutions Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Ablative Solutions Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioStar VenturesVenture CapitalMinority000 0000000 0000
Grand AngelsAngel GroupMinority000 0000000 0000
Michigan Accelerator Fund 1Venture CapitalMinority000 0000000 0000
BioStar Ventures Venture Capital
Grand Angels Angel Group
Michigan Accelerator Fund 1 Venture Capital

Ablative Solutions Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Tim Fischell MDCo-Founder, Chief Medical Officer, Chief Executive Officer & Board Member
Vartan Ghazarossian Ph.DPresident, Chief Operating Officer & Board Member
Helen Parise Ph.DVice President, Biometrics
Nicole HarataniVice President, Global Clinical and Regulatory Affairs
Mary AdamsVice President, Global Quality Systems and Compliance
Tim Fischell MD Co-Founder, Chief Medical Officer, Chief Executive Officer & Board Member
Vartan Ghazarossian Ph.D President, Chief Operating Officer & Board Member
Helen Parise Ph.D Vice President, Biometrics
Nicole Haratani Vice President, Global Clinical and Regulatory Affairs
Mary Adams Vice President, Global Quality Systems and Compliance

Ablative Solutions Board Members (9)

NameRepresentingRoleSinceContact
Info
Dale GroganMichigan Accelerator Fund 1Managing Director000 0000
David Fischell Ph.DSelfFounder & Chairman000 0000
David Rosen MDSelfBoard Member000 0000
Paul BuckmanSelfBoard Member000 0000
Phillip Torrence JDHonigman Miller Schwartz and CohnManaging Partner000 0000
Dale Grogan Managing Director Michigan Accelerator Fund 1
David Fischell Ph.D Founder & Chairman Self
David Rosen MD Board Member Self
Paul Buckman Board Member Self
Phillip Torrence JD Managing Partner Honigman Miller Schwartz and Cohn
Request full access to PitchBook